Scroll to Top
Industries contribution to IMI projects - Your questions answered
14 April 2016
The Innovative Medicines Initiative (IMI) is a Joint Undertaking (JU) between the European Union (EU), represented by the European Commission, and the European Federation of ...
Animal welfare and the European Pharmaceutical industry - Your questions answered
01 April 2016
Medical research continues apace. It needs to, as many health challenges still remain unmet. Animal studies continue to play an invaluable role in meeting these ...
Report on a meeting between the EFPIA HTA WG and DG SANTE on 16 February 2016
24 March 2016
On 16 February 2016 DG SANTE was invited to the EFPIA Working Group on HTA. The purpose of the meeting was to present the EU ...
About the EFPIA Disclosure Code
17 March 2016
The EFPIA Disclosure Code is a code of conduct that requires all EFPIA member companies and companies that are members of EFPIA member associations to disclose transfers ...
The EFPIA Disclosure Code: Your Questions Answered
17 March 2016
IPROVE report: A Strategic European Roadmap for the Vaccines of Tomorrow: a Joint Stakeholder Reflection
17 March 2016
The Innovation Partnership for a Roadmap on Vaccines in Europe (IPROVE) represents a collaborative effort by the leading vaccine experts in Europe to develop a ...
Enhancing Value in European Health Systems: The Role of Outcomes Measurement - Consensus Document
15 March 2016
Health systems across the European Union are confronting numerous challenges – from ageing populations and the sustainable financing of health care, to wide variations in ...
EFPIA Patient Think Tank – Issue Summary December 2015
07 March 2016
The EFPIA Patient Think Tank provides a forum for an open exchange of ideas, information and perspectives between patient organisations and industry on topical issues ...
Working Together for Patients: Role of Consultancy
29 February 2016
Collaboration between industry and health professionals benefits patients. It is a relationship that has delivered numerous innovative medicines and changed the way many diseases impact ...
Clinical Trials Implementation Monitor Summary Q3 - Update January 2016
16 February 2016
This continuous survey (The Clinical Trials Implementation Monitor (or “CTiMonitor”) aims to build knowledge on how the implementation of the Clinical Trials Regulation (CTR), (EU) ...
Page 4 of 12
The Pharmaceutical Industry in a Global Economy: What Drives EU Exports of Pharmaceuticals Overseas
15 July 2014
Since 2001, EFPIA has collaborated with the College of Europe to establish the “EFPIA Award”, created with the aim of highlighting a Master’s Thesis covering ...
Reports & Studies
Facts & Figures
Follow us on
Add us on
Check us out on
EFPIA Brussels Office
Leopold Plaza Building
Rue du Trône 108
B-1050 Brussels (Belgium)
Tel: +32 (0)2 626 25 55
European Biopharmaceutical Enterprises
INNOVATIVE MEDICINES INITIATIVE
Educational Events & Ethical Evaluation
EFPIA 2017 - All rights reserved -
- Design by
Morris & Chapman